Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 19,000
+800 (4.40%)
At close: May 11, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 43.83 billion as of May 11, 2026. Its market cap has increased by 69.79% in one year.
Market Cap
43.83B
Enterprise Value
n/a
Revenue
449.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
19,000.00
Market Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 43.83B, a decrease of -25.19%. That is a compound annual growth rate of -9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 43.83B | 26.67% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Sciences | 60.87B |
| EyeGene | 59.83B |
| ADBiotech | 57.86B |
| J2KBIO | 46.60B |
| Parataxis Korea | 44.13B |
| Poongjeon Pharmacy CO.,LTD. | 40.98B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |